SAB Biotherapeutics Warrant
SABSW
SABSW
24 hedge funds and large institutions have $4.04M invested in SAB Biotherapeutics Warrant in 2021 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 6 increasing their positions, 4 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
Holders
24
Holding in Top 10
–
Calls
$58K
Puts
–
Top Buyers
| 1 | +$214K | |
| 2 | +$188K | |
| 3 | +$108K | |
| 4 |
SCM
Shaolin Capital Management
Miami,
Florida
|
+$56.6K |
| 5 |
KC
Kepos Capital
New York
|
+$34.6K |
Top Sellers
| 1 | -$171K | |
| 2 | -$157K | |
| 3 | -$131K | |
| 4 |
PMAM
Picton Mahoney Asset Management
Toronto,
Ontario, Canada
|
-$115K |
| 5 |
GCL
Glazer Capital LLC
New York
|
-$109K |